In the type 2 diabetes group, subjects harboring the AA/AG genotype of rs1761667 were fivefold more likely to have CD36 gene methylation than subjects harboring the GG genotype (OR = 5.35 [1.59–17.96], p < 0.01). This evidence concerns the gene CD36 and type 2 diabetes mellitus.